Lördag 21 December | 18:00:41 Europe / Stockholm

Bifogade filer

Kalender

Tid*
2025-08-19 14:30 Kvartalsrapport 2025-Q2
2025-05-18 14:30 Kvartalsrapport 2025-Q1
2025-02-14 N/A Årsstämma
2025-02-14 15:00 Bokslutskommuniké 2024
2024-11-29 - Kvartalsrapport 2024-Q3
2024-08-21 - Kvartalsrapport 2024-Q2
2024-05-31 - Årsstämma
2024-05-22 - Kvartalsrapport 2024-Q1
2024-05-17 - X-dag ordinarie utdelning EEVIA 0.00 SEK
2024-02-14 - Bokslutskommuniké 2023
2023-11-22 - Kvartalsrapport 2023-Q3
2023-08-23 - Kvartalsrapport 2023-Q2
2023-06-26 - Årsstämma
2023-05-26 - X-dag ordinarie utdelning EEVIA 0.00 SEK
2023-05-16 - Kvartalsrapport 2023-Q1
2023-02-24 - Bokslutskommuniké 2022
2022-11-25 - Kvartalsrapport 2022-Q3
2022-10-11 - Extra Bolagsstämma 2022
2022-08-29 - Kvartalsrapport 2022-Q2
2022-06-22 - X-dag ordinarie utdelning EEVIA 0.00 SEK
2022-06-21 - Årsstämma
2022-05-27 - Kvartalsrapport 2022-Q1
2022-02-25 - Bokslutskommuniké 2021
2021-12-09 - Extra Bolagsstämma 2021
2021-11-16 - Kvartalsrapport 2021-Q3
2021-08-13 - Kvartalsrapport 2021-Q2
2021-06-22 - Årsstämma
2021-05-18 - Kvartalsrapport 2021-Q1

Beskrivning

LandFinland
ListaSpotlight
SektorHandel & varor
IndustriDetaljhandel
Eevia Health är verksamma inom life science. Bolaget erbjuder produktionsprotokoll och procedurer för att leverera ekologiska produkter till internationella kunder. Produkterna säljs till företagskunder och inkluderar ingredienser till producenter av kosttillskott, livsmedel och kosmetika på global basis. Produkterna innefattar exempelvis blåbär, chaga-svamp och tallbark. Eevia Health grundades 2017 och har sitt huvudkontor i Seinäjoki, Finland.
2024-07-19 10:30:05

Eevia Health Plc ("Eevia" or "The Company") has received an 80 KEUR sales order for Lingonberry extracts from a Finnish beauty brand.

The end customer is a well-known Finnish manufacturer and brand owner in the cosmetics industry, known for marketing and selling premium cosmetic products across Europe, Asia, and North America. The company is recognized for its unwavering commitment to sustainable development practices and its natural Arctic product lines.

The sales value of this order is approximately 80 KEUR. The product is a customized lingonberry extracts, standardized on key polyphenols. It is manufactured using a custom-designed specialized processing protocol, exclusively for this customer. This order aligns with the expected repeat sales of these products.

For further information, please contact:

Stein Ulve, CEO, Eevia Health Plc

Email: stein.ulve@eeviahealth.com

Telephone: +358400 22 5967

INFORMATION ABOUT EEVIA HEALTH PLC

Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients to dietary supplements and food brands globally, and these global brands utilize the ingredients in their consumer product formulas.

Eevia Health manufactures 100% organically certified plant extracts. Our commitment to sustainable and organic manufacturing practices, such as wild harvesting our raw materials and operating a modern green chemistry production facility, ensures the highest quality products for our customers.

Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. In June 2021, Eevia listed its shares on the Spotlight Stock Market in Sweden under the short name EEVIA (https://spotlightstockmarket.com/en/companies/irabout?InstrumentId=XSAT000085FD).

To learn more, please visit www.eeviahealth.comor follow Eevia Health on LinkedIn @EeviaHealth.